FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Aug 22, 2011
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on August 22, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- August 22, 2011
- Product Type
- Biologics
View Company Profile
ID · 432d2c58-24cf-48b2-a255-662a58a79648
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 740512
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 640.63(a)Determination not made on day of collection
- 21 CFR 630.40(a)Notification
- 21 CFR 630.40(a)Supplemental results
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2025 | Not classified | Los Angeles District Office | |
| July 25, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 19, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1252470 - 2025-02-27
- FDA Inspection 1059921 - 2018-07-25
- FDA Inspection 872475 - 2014-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.